Abstract
Objectives We investigated the feasibility and validity of establishing a nationwide e-cohort of individuals with a diagnosis of ADHD and/or ASD for future longitudinal research.
Design Individuals with a childhood diagnosis of ADHD/ASD as recorded on routinely available healthcare datasets were compared with matched controls and a sample of directly assessed individuals with ADHD.
Setting This study utilised data from the Welsh Secure Anonymised Information Linkage (SAIL) Databank in Wales, UK. Routinely collected data from primary care, Emergency Department and hospital admissions were linked at person level.
Participants All individuals in Wales, UK born between 01/01/1991 and 31/12/2000. Individuals with a recorded diagnosis of ADHD and/or ASD by age 18 years were identified using ICD-10 and NHS Read codes and matched to three controls each and 154 individuals with ADHD recruited from an established research study.
Outcome measures Recorded service use for anxiety and depression, alcohol and drug use and self-harm including Emergency Department use in young adulthood (age 16 years to 25).
Results 7726 individuals had a recorded diagnosis of ADHD (80% male) and 5001 of ASD (79% male); % and 0.9% of the population respectively. Cox’s regression analyses showed ADHD was associated with increased risks of anxiety/depression (HR:2.36, 95% CI:2.20,2.53), self-harm (HR: 5.70, 95% CI:5.07,6.40), alcohol (HR:3.95, 95%CI:3.42,4.56), drug use (HR:5.88, 95%CI:5.08,6.80) and Emergency department service use (HR:1.36, 95%CI:1.31,1.41). Those with ASD were at increased risk of anxiety/depression (HR:2.11, 95%CI: 1.91,2.34), self-harm (HR:2.93, 95%CI: 2.45,3.50) and drug use (HR:2.21, 95%CI: 1.66,2.95) but not alcohol use. The ADHD e-cohort were similar to the directly assessed cohort.
Conclusions Our identification strategy demonstrated the feasibility of establishing a large e-cohort of those with ADHD/ASD with expected patterns of poorer early adult outcomes, demonstrating a valid method of identifying large samples for future longitudinal studies without selective attrition.
Strengths and limitations of this study
This study used population wide administrative data from a well-established and comprehensive databank
Data from both primary and secondary care was combined
The study utilised a directly assessed sample of those with ADHD to help validate the establishment of the administratively identified sample
Not all individuals had passed through the whole follow up period at the end of the study
Studies utilising administrative data is dependent upon that data having been collected an recorded.
Competing Interest Statement
AT is on the executive board of the UK Charity ADHD Foundation (unpaid). All salary comes from Cardiff University only. KL has received a speaker’s fee from Medice on a topic unrelated to this research. All other authors declare no conflicts of interest.
Funding Statement
This study was funded by a Wellcome Trust Institutional Strategic Support Fund awarded by Cardiff University, Grant number (Grant ref: AC1710IF04) and the National Centre for Mental Health (NCMH) which is funded by Health and Care Research Wales (Grant ref: 517191). LR is supported by the Wolfson Foundation. As this research was funding in whole, or in part, by the Wellcome Trust, for the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the NHS Wales Research Ethics Committee (14/WA/0157). Access to data from the SAIL databank was approved by the Information Governance Review Panel (IGRP) (project number 0712). Patient consent is not required for publication.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author emails: Kate Langley: langleyk{at}cardiff.ac.uk; Marcos Del Pozo-Banos: m.delpozobanos{at}swansea.ac.uk; Søren Dalsgaard: sdalsgaard.ncrr{at}au.dk;, Shantini Paranjothy: shantini.paranjothy{at}abdn.ac.uk; Lucy Riglin: RiglinL{at}cardiff.ac.uk; Ann John: a.john{at}swansea.ac.uk; Anita Thapar: Thapar{at}cardiff.ac.uk
Funding: This study was funded by a Wellcome Trust Institutional Strategic Support Fund awarded by Cardiff University, Grant number (Grant ref: AC1710IF04) and the National Centre for Mental Health (NCMH) which is funded by Health and Care Research Wales (Grant ref: 517191). LR is supported by the Wolfson Foundation. As this research was funding in whole, or in part, by the Wellcome Trust, for the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.
Conflicts of interest: AT is on the executive board of the UK Charity ADHD Foundation (unpaid). All salary comes from Cardiff University only. KL has received a speaker’s fee from Medice on a topic unrelated to this research. All other authors declare no conflicts of interest.
Ethical approval: This study was approved by the NHS Wales Research Ethics Committee (14/WA/0157). Access to data from the SAIL databank was approved by the Information Governance Review Panel (IGRP) (project number 0712). Patient consent is not required for publication.
Data availability statement: Data within this study are available in the SAIL Databank. Access to the SAIL Databank is subject to review by and independent Information Governance Review Panel (IGRP). The IGRP gives careful consideration to each project to ensure proper and appropriate use of SAIL data, and approval from the IGRP is necessary to access any data. Once access has been granted, it is gained through the SAIL Gateway: a privacy protecting safe haven and remote access system. Details on how to access data from the SAIL Databank is available here: https://saildatabank.com/data/.
Data Availability
Data within this study are available in the SAIL Databank. Access to the SAIL Databank is subject to review by and independent Information Governance Review Panel (IGRP). The IGRP gives careful consideration to each project to ensure proper and appropriate use of SAIL data, and approval from the IGRP is necessary to access any data. Once access has been granted, it is gained through the SAIL Gateway: a privacy protecting safe haven and remote access system. Details on how to access data from the SAIL Databank is available here: https://saildatabank.com/data/.
